{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:10:59Z","timestamp":1775218259968,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.7759\/cureus.106361","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:37:58Z","timestamp":1775216278000},"source":"Crossref","is-referenced-by-count":0,"title":["Obstructive Hypertrophic Cardiomyopathy and Interarterial Anomalous Aortic Origin of the Right Coronary Artery (AAORCA) Presenting With Syncope: Multimodal Diagnostic Assessment and Individualized Management"],"prefix":"10.7759","author":[{"given":"Jonathan","family":"Moyambi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfakihi Ahmed","family":"Said Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tagueniti","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brahim","family":"Meftout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drighil","family":"Abdenasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron BJ","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995, 92:785-9. 10.1161\/01.cir.92.4.785","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjcpc.2023.03.001","article-title":"Anomalous aortic origin of the right coronary artery: invasive haemodynamic assessment in adult patients with high-risk anatomic features","volume":"2","author":"Verheijen DB","year":"2023","unstructured":"Verheijen DB, Egorova AD, Jongbloed MR, et al.. Anomalous aortic origin of the right coronary artery: invasive haemodynamic assessment in adult patients with high-risk anatomic features. CJC Pediatr Congenit Heart Dis. 2023, 2:124-33. 10.1016\/j.cjcpc.2023.03.001","journal-title":"CJC Pediatr Congenit Heart Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203344","article-title":"Double trouble: hypertrophic cardiomyopathy coexistent with malignant anomalous right coronary artery","volume":"2014","author":"Liddy S","year":"2014","unstructured":"Liddy S, Roy AK, McCreery C. Double trouble: hypertrophic cardiomyopathy coexistent with malignant anomalous right coronary artery. BMJ Case Rep. 2014, 2014:bcr2013203344. 10.1136\/bcr-2013-203344","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5603\/KP.2018.0141","article-title":"Hypertrophic obstructive cardiomyopathy with anomalous left circumflex coronary artery","volume":"76","author":"Wo\u017anica A","year":"2018","unstructured":"Wo\u017anica A, Tyczy\u0144ski P, Brzozowski P, Skowro\u0144ski J, R\u00f3\u017ca\u0144ski J, Witkowski A. Hypertrophic obstructive cardiomyopathy with anomalous left circumflex coronary artery. Kardiol Pol. 2018, 76:1118. 10.5603\/KP.2018.0141","journal-title":"Kardiol Pol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2023.101690","article-title":"ANOCOR registry (in French)","volume":"72","author":"Aubry P","year":"2023","unstructured":"Aubry P, du Fretay XH, Zendjebil S, et al.. ANOCOR registry (in French). Ann Cardiol Angeiol (Paris). 2023, 72:101690. 10.1016\/j.ancard.2023.101690","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1028","article-title":"2018 AHA\/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive\u00a0Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout KK","year":"2019","unstructured":"Stout KK, Daniels CJ, Aboulhosn JA, et al.. 2018 AHA\/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive\u00a0Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019, 73:1494-563. 10.1016\/j.jacc.2018.08.1028","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen SR","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, et al.. 2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020, 142:e558-631. 10.1161\/CIR.0000000000000937","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron MS","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG, et al.. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006, 114:2232-9. 10.1161\/CIRCULATIONAHA.106.644682","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2006.08.001","article-title":"Pathophysiology and treatment of hypertrophic cardiomyopathy","volume":"49","author":"Sherrid MV","year":"2006","unstructured":"Sherrid MV. Pathophysiology and treatment of hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 2006, 49:123-51. 10.1016\/j.pcad.2006.08.001","journal-title":"Prog Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto I","year":"2020","unstructured":"Olivotto I, Oreziak A, Barriales-Villa R, et al.. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020, 396:759-69. 10.1016\/S0140-6736(20)31792-X","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen SR","year":"2024","unstructured":"Ommen SR, Ho CY, Asif IM, et al.. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1239-311. 10.1161\/CIR.0000000000001250","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan RH","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I, et al.. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014, 130:484-95. 10.1161\/CIRCULATIONAHA.113.007094","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476436-obstructive-hypertrophic-cardiomyopathy-and-interarterial-anomalous-aortic-origin-of-the-right-coronary-artery-aaorca-presenting-with-syncope-multimodal-diagnostic-assessment-and-individualized-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:37:58Z","timestamp":1775216278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476436-obstructive-hypertrophic-cardiomyopathy-and-interarterial-anomalous-aortic-origin-of-the-right-coronary-artery-aaorca-presenting-with-syncope-multimodal-diagnostic-assessment-and-individualized-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.106361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}